Patent · US Active

P2X3 receptor antagonists for treatment of pain

US8569512B2 · kind B2 · utility

6Cited by
4References
11Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 15, 2010
Grant dateOct 29, 2013
Priority date
Expiry dateJul 15, 2030

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D495/04
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The subject invention relates to novel P2X3 receptor antagonists that play a critical role in treating disease states associated with pain, in particular peripheral pain, inflammatory pain, or tissue injury pain that can be treated using a P2X3 receptor subunit modulator.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.